* AVITA Medical Inc reported a quarterly adjusted loss of 26 cents per share for the quarter ended in January, lower than the same quarter last year, when the company reported EPS of -8 cents. The lone analyst forecast for the quarter was for a loss of 26 cents per share. Wall Street expected results to range from -66 cents to -45 cents per share.
* Revenue rose 29.3% to $15.20 million from a year ago; analysts expected $14.52 million.
* AVITA Medical Inc's reported EPS for the quarter was a loss of 12 cents.
* The company reported a quarterly loss of $15.39 million.
* AVITA Medical Inc shares had risen by 3.3% this quarter and lost 41.7% so far this year.
FORECAST CHANGES
* The mean earnings estimate of analysts had fallen by about 36.2% in the last three months.
* In the last 30 days, one analyst negatively revised an earnings estimate
RECOMMENDATIONS
* The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 4 "strong buy" or "buy," 4 "hold" and no "sell" or "strong sell."
* The average consensus recommendation for the biotechnology & medical research peer group is also "buy"
Wall Street's median 12-month price target for AVITA Medical Inc is A$4.10 This summary was machine generated from LSEG data August 9 at 02:24 a.m. UTC. All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING ESTIMATE ACTUAL BEAT, MET,
MISSED
Jun. 30 2024 -0.54 -0.12 Beat
Mar. 31 2024 -0.47 -0.15 Beat
Dec. 31 2023 -0.38 -0.06 Beat
Sep. 30 2023 -0.41 -0.07 Beat
Comments